IMHR Researchers

Jacques Bradwejn (MD)

Dr Jacques Bradwejn trained in medicine at the University of Sherbrooke and in psychiatry at McGill University. He completed a research fellowship in psychopharmacology at McGill University and in neuropsychopharmacology at the University of Montreal. Dr. Bradwejn has also completed the Wharton Certificate of Professional Development at the Wharton School, University of Pennsylvania and is a member of the Wharton Fellows Program.

His main research interest has been in the field of anxiety disorders. He was the first to report that administration of cholecystokinin-tetrapeptide (CCK-4) induces panic attacks in patients suffering from panic disorder and has gained an international reputation for his work with this neuropeptide. He has recently expanded his research interests to integration of biological and psychological approaches in the treatment of anxiety disorders and to approaches used by Complementary Medicines.

Dr. Bradwejn has served on several scientific organizations. He has served as chair of grant review committees for the Fond de la Recherche en Santé du Québec and as a grant committee member for the Medical Research Council of Canada. He was President of the Canadian College of Neuropsychopharmacology. He was the founding president of a provincial association for research and education in anxiety disorders in Quebec (ATAQ) and a founding member of the Canadian Network for Mood and Anxiety Treatment.

Dr. Bradwejn has also served on many University, Hospital and Research Institute Committees and was a member of the "Setting Directions" strategic directions committee for the Faculty of Medicine. Dr. Bradwejn was a member of major government committees such as the Champlain District Mental Health Implementation Task Force; East Region Ministry of Health Long Term Care Integration Advisory Group; Federal Advisory Commission on Chronic Illness; Advisory Committee, Ontario Center of Excellence for Child and Youth.

Dr. Bradwejn has been active in treatment reviews and best practice design for mental health services. He has co-chaired the committee for a program funded by the Ministry of Health of Ontario on the creation of the Ontario Clinical Guidelines to Anxiety Disorders. The guidelines were distributed to Ontario family physicians in 2001. Dr Bradwejn has published over 160 articles and book chapters, has made more than 400 scientific and educational conferences and over 350 educational media interventions. Before accepting the tenure as Acting Dean for the Faculty of Medicine, Dr. Bradwejn was serving as Chair of the Department of psychiatry of the University of Ottawa and as Psychiatrist-in-Chief at the Royal Ottawa Mental Health Centre, positions he has held since January 1998 and as Head of Psychiatry of the Ottawa Hospital since January 1999. Prior to these positions, he held positions at McGill University as Associate Professor of Psychiatry and at the University of Toronto as Professor of Psychiatry.

Email:

Publications